@ARTICLE{
author={Thongprasert Sumitra|,Geater SL|,Clement D|,Abdelaziz A|,Reyer-Igama J|,Jovanovic D|,Suresh S|,Cseh Agnieszka|,Gaafar Rabab|},
year={2018},
title={Second-line afatinib for patients with locally advanced or metastatic NSCLC harbouring common EGFR mutations: A phase IV study},
journal={JOURNAL OF THORACIC ONCOLOGY},
volume={13},
number={4},
pages={S94-S94},
document_type={Meeting Abstract},
}